Loading...
Loading...
India's plasma imports from CANADA total $43.9K across 69 shipments from 15 foreign suppliers. BIOMEDICA DIAGNOSTICS INC leads with $16.2K in import value; the top 5 suppliers together control 88.8% of this origin. Leading Indian buyers include TULIP DIAGNOSTICS PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for plasma โ a diversified sourcing base with multiple active suppliers from CANADA.

BIOMEDICA DIAGNOSTICS INC is the leading Plasma supplier from CANADA to India, with import value of $16.2K across 6 shipments. The top 5 suppliers โ BIOMEDICA DIAGNOSTICS INC, AFFINITY BIOLOGICALS INC, CLIANTHA RESEARCH, STEMCELL TECHNOLOGIES CANADA INC., SYNEOS HEALTH CLINIQUE INC โ collectively account for 88.8% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | BIOMEDICA DIAGNOSTICS INC | $16.2K | 6 | 37.0% |
| 2 |
| AFFINITY BIOLOGICALS INC |
| $11.2K |
| 2 |
| 25.6% |
| 3 | CLIANTHA RESEARCH | $5.1K | 7 | 11.6% |
| 4 | STEMCELL TECHNOLOGIES CANADA INC. | $4.6K | 4 | 10.4% |
| 5 | SYNEOS HEALTH CLINIQUE INC | $1.9K | 1 | 4.3% |
| 6 | KINGFISHER INTERNATIONAL INC | $1.2K | 2 | 2.7% |
| 7 | CAP C/O PTS | $1.1K | 7 | 2.5% |
| 8 | BIO PHARMA SERVICES INC | $598 | 2 | 1.4% |
| 9 | CAP C O PTS | $405 | 4 | 0.9% |
| 10 | BIOPHARMA SERVICES INC | $394 | 2 | 0.9% |
| 11 | BIOPHARMA SERVICES INC. | $347 | 7 | 0.8% |
| 12 | KINGFISHER INTERNATIONAL INC. | $242 | 1 | 0.6% |
| 13 | CLILANTHA RESEARCH | $197 | 1 | 0.4% |
| 14 | CAP C/O (PTS) | $152 | 1 | 0.3% |
| 15 | KINGFISHER INTERNATIONAL | $130 | 1 | 0.3% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | TULIP DIAGNOSTICS PRIVATE LIMITED | $27.5K | 8 | 62.6% |
| 2 | CLIANTHA RESEARCH LIMITED | $6.2K | 11 | 14.2% |
| 3 | JUBILANT BIOSYS LIMITED | $4.6K | 4 | 10.4% |
| 4 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $1.9K | 1 | 4.3% |
| 5 | ACTIMUS BIOSCIENCES PRIVATE LIMITED | $1.5K | 4 | 3.5% |
| 6 | BECTON DICKINSON INDIA PRIVATE LIMITED. | $1.1K | 7 | 2.4% |
| 7 | BECTON DICKINSON INDIA PRIVATE LIMITED | $609 | 5 | 1.4% |
| 8 | MYLAN LABORATORIES LIMITED | $407 | 8 | 0.9% |
| 9 | MEDLERA HEALTHCARE | $48 | 1 | 0.1% |
| 10 | EUROFINS ADVINUS BIOPHARMA SERVICES INDIA PRIVATE | $37 | 5 | 0.1% |
| 11 | RAPHA DIAGNOSTICS PRIVATE LIMITED | $28 | 2 | 0.1% |
| 12 | ECRON ACUNOVA LIMITED | $20 | 2 | 0.0% |
| 13 | LUPIN LIMITED | $17 | 2 | 0.0% |
| 14 | MERIL DIAGNOSTICS PRIVATE LIMITED | $13 | 6 | 0.0% |
| 15 | OSCAR MEDICARE PRIVATE LIMITED | $1 | 1 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Plasma suppliers from CANADA to India include BIOMEDICA DIAGNOSTICS INC, AFFINITY BIOLOGICALS INC, CLIANTHA RESEARCH. The leading supplier is BIOMEDICA DIAGNOSTICS INC with import value of $16.2K USD across 6 shipments. India imported Plasma worth $43.9K USD from CANADA in total across 69 shipments.
India imported Plasma worth $43.9K USD from CANADA across 69 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Plasma sourced from CANADA include TULIP DIAGNOSTICS PRIVATE LIMITED, CLIANTHA RESEARCH LIMITED, JUBILANT BIOSYS LIMITED. The largest buyer is TULIP DIAGNOSTICS PRIVATE LIMITED with $27.5K in imports across 8 shipments.
The total value of Plasma imports from CANADA to India is $43.9K USD, across 69 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
69 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists